Cita APA

Rashid, D. S. A., O’Reilly, D. P., dunne, D. p., Alderdice, M. M., Flannery, D. T., Prise, P. K., . . . McArt, D. D. (2017). PP28. THERAPEUTIC COMPOUND DISCOVERY AND VALIDATION OF DRUGS TARGETING A RECURRENT GLIOBLASTOMA (GBM) PHENOTYPE USING LINCS COMPOUNDS VIA QUADRATIC ANALYSES. Neuro Oncol.

Chicago Style Citation

Rashid, Dr Shahnaz Al, Dr Paul O’Reilly, Dr philip dunne, Mr Matthew Alderdice, Dr Thomas Flannery, Prof Kevin Prise, Dr Shu-Dong Zhang, i Dr Darragh McArt. "PP28. THERAPEUTIC COMPOUND DISCOVERY AND VALIDATION OF DRUGS TARGETING A RECURRENT GLIOBLASTOMA (GBM) PHENOTYPE USING LINCS COMPOUNDS VIA QUADRATIC ANALYSES." Neuro Oncol 2017.

Cita MLA

Rashid, Dr Shahnaz Al, et al. "PP28. THERAPEUTIC COMPOUND DISCOVERY AND VALIDATION OF DRUGS TARGETING A RECURRENT GLIOBLASTOMA (GBM) PHENOTYPE USING LINCS COMPOUNDS VIA QUADRATIC ANALYSES." Neuro Oncol 2017.